Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Mazanetz

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Physical Chemistry. B|September 21, 2016
Assessment of Hydration Thermodynamics at Protein Interfaces with Grid Cell TheoryGeorgios Gerogiokas, Michelle W Y Southey, Michael P Mazanetz, et al.
International Journal of Molecular Sciences|September 28, 2023
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial ParticipantsMohammad Arastoo, Michael P Mazanetz, Sonya Miller, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Physical Chemistry. B|September 21, 2016
Assessment of Hydration Thermodynamics at Protein Interfaces with Grid Cell TheoryGeorgios Gerogiokas, Michelle W Y Southey, Michael P Mazanetz, et al.
International Journal of Molecular Sciences|September 28, 2023
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial ParticipantsMohammad Arastoo, Michael P Mazanetz, Sonya Miller, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Pageof 2